相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer
Mohammad Jaber et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E. Senkus et al.
ANNALS OF ONCOLOGY (2013)
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2013)
Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact
Frank Gieseler et al.
CELL COMMUNICATION AND SIGNALING (2013)
Transactivation of the PAR1-PAR2 Heterodimer by Thrombin Elicits β-Arrestin-mediated Endosomal Signaling
Huilan Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Regulation of human protease-activated receptor 1 (hPar1) gene expression in breast cancer by estrogen
Zaidoun Salah et al.
FASEB JOURNAL (2012)
We Can Do It Together: PAR1/PAR2 Heterodimer Signaling in VSMCs
Rafal Pawlinski et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Protease-Activated Receptor-2 Modulates Protease-Activated Receptor-1-Driven Neointimal Hyperplasia
Leila M. Sevigny et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
PAR1 and PAR2 Couple to Overlapping and Distinct Sets of G Proteins and Linked Signaling Pathways to Differentially Regulate Cell Physiology
Kelly L. Mccoy et al.
MOLECULAR PHARMACOLOGY (2010)
Etk/Bmx Regulates Proteinase-Activated-Receptor1 (PAR1) in Breast Cancer Invasion: Signaling Partners, Hierarchy and Physiological Significance
Irit Cohen et al.
PLOS ONE (2010)
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2009)
Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis
Eric Yang et al.
CANCER RESEARCH (2009)
Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice
Henri H. Versteeg et al.
CANCER RESEARCH (2008)
Inhibition of tissue factor signaling suppresses tumor growth
Henri H. Versteeg et al.
BLOOD (2008)
Insulin-like growth factor 1 differentially regulates estrogen receptor-dependent transcription at estrogen response element and AP-1 sites in breast cancer cells
Sandra Cascio et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Long-term treatment with tamoxifen facilitates translocation of estrogen receptor α out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells
Ping Fan et al.
CANCER RESEARCH (2007)
REporting recommendations for tumor MARKer prognostic studies (REMARK)
Lisa M. McShane et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells
DR Morris et al.
CANCER RESEARCH (2006)
Measuring proliferation in breast cancer: practicalities and applications
Mark J. Beresford et al.
BREAST CANCER RESEARCH (2006)
Signaling of the tissue factor coagulation pathway in angiogenesis and cancer
M Belting et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
New insight into estrogen receptor-alpha function and its implication for endocrine therapy resistance in breast cancer
R Schiff et al.
BREAST CANCER RESEARCH (2005)
Multiple independent functions of arrestins in the regulation of protease-activated receptor-2 signaling and trafficking
L Stalheim et al.
MOLECULAR PHARMACOLOGY (2005)
Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion
MA Booden et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor
ER Levin
MOLECULAR ENDOCRINOLOGY (2003)
S-phase fraction and urokinase plasminogen activator are better markers for distant recurrences than Nottingham Prognostic Index and histologic grade in a prospective study of premenopausal lymph node-negative breast cancer
P Malmström et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Thrombin signalling and protease-activated receptors
SR Coughlin
NATURE (2000)
Thrombin responses in human endothelial cells - Contributions from receptors other than Par1 include the transactivation of Par2 by thrombin-cleaved Par1
PJ O'Brien et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
